Cargando…

PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH

Detalles Bibliográficos
Autores principales: Carda #, J. P., Gomes #, R., Jorge, J., Gonçalves, A. C., Marques, B., Alves, R., Sarmento-Ribeiro, A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429100/
http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98
_version_ 1784779329393131520
author Carda #, J. P.
Gomes #, R.
Jorge, J.
Gonçalves, A. C.
Marques, B.
Alves, R.
Sarmento-Ribeiro, A. B.
author_facet Carda #, J. P.
Gomes #, R.
Jorge, J.
Gonçalves, A. C.
Marques, B.
Alves, R.
Sarmento-Ribeiro, A. B.
author_sort Carda #, J. P.
collection PubMed
description
format Online
Article
Text
id pubmed-9429100
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94291002022-08-31 PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH Carda #, J. P. Gomes #, R. Jorge, J. Gonçalves, A. C. Marques, B. Alves, R. Sarmento-Ribeiro, A. B. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429100/ http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Carda #, J. P.
Gomes #, R.
Jorge, J.
Gonçalves, A. C.
Marques, B.
Alves, R.
Sarmento-Ribeiro, A. B.
PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title_full PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title_fullStr PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title_full_unstemmed PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title_short PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
title_sort pb1857: nrf2 modulators in chronic lymphocytic leukemia patients: a possible new therapeutic approach
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429100/
http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98
work_keys_str_mv AT cardajp pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT gomesr pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT jorgej pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT goncalvesac pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT marquesb pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT alvesr pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach
AT sarmentoribeiroab pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach